Cargando…

GATA2 deficiency and related myeloid neoplasms

The GATA2 gene codes for a hematopoietic transcription factor that through its two zinc fingers (ZF) can occupy GATA-DNA motifs in a countless number of genes. It is crucial for the proliferation and maintenance of hematopoietic stem cells. During the past 5 years, germline heterozygous mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wlodarski, Marcin W., Collin, Matthew, Horwitz, Marshall S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650112/ https://www.ncbi.nlm.nih.gov/pubmed/28637621 http://dx.doi.org/10.1053/j.seminhematol.2017.05.002

Ejemplares similares

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
por: Mir, Muhammad A, et al.
Publicado: (2015)

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1
por: Singh, Preeti, et al.
Publicado: (2021)

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
por: Kozyra, Emilia J., et al.
Publicado: (2020)

GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects
por: Kotmayer, Lili, et al.
Publicado: (2022)

Myeloid Neoplasms in the Guise of Nutritional Deficiency
por: Parthasarathy, Veda
Publicado: (2012)

Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
por: Marin-Bejar, Oskar, et al.
Publicado: (2023)

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
por: Al Seraihi, Ahad F., et al.
Publicado: (2018)

P698: CRISPR/CAS9 GENE EDITING IN HEMATOPOIETIC STEM CELLS TO MODEL CLONAL COMPETITION IN VIVO AND IN VITRO FOR GATA2 DEFICIENCY
por: Romero-Moya, Damia, et al.
Publicado: (2023)

Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Hahn, Christopher N., et al.
Publicado: (2011)

Haematopoietic and immune defects associated with GATA2 mutation
por: Collin, Matthew, et al.
Publicado: (2015)

Differential Requirement of Gata2a and Gata2b for Primitive and Definitive Myeloid Development in Zebrafish
por: Peña, Oscar A., et al.
Publicado: (2021)

Somatic genetic alterations predict hematological progression in GATA2 deficiency
por: Largeaud, Laetitia, et al.
Publicado: (2023)

Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency
por: Sologuren, Ithaisa, et al.
Publicado: (2018)

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
por: Geng, Xiangrong, et al.
Publicado: (2022)

P718: EPIGENOME PROFILING REVEALS ABERRANT DNA METHYLATION SIGNATURE IN GATA2 DEFICIENCY
por: Marin-Bejar, Oskar, et al.
Publicado: (2023)

GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
por: Yang, Naery, et al.
Publicado: (2018)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
por: Tao, Yan-Fang, et al.
Publicado: (2015)

GATA2 Deficiency and Epstein–Barr Virus Disease
por: Cohen, Jeffrey I.
Publicado: (2017)

West Nile virus encephalitis in GATA2 deficiency
por: Rosa, Jaime S., et al.
Publicado: (2019)

GATA2 deficiency syndrome: A decade of discovery
por: Homan, Claire C., et al.
Publicado: (2021)

GATA 2 Deficiency: Focus on Immune System Impairment
por: Fabozzi, Francesco, et al.
Publicado: (2022)

The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency
por: Santiago, Marta, et al.
Publicado: (2023)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome
por: Bortnick, Rachel, et al.
Publicado: (2021)

Therapy-related myeloid neoplasms: clinical perspectives
por: Fianchi, Luana, et al.
Publicado: (2018)

A Panoply of Rheumatological Manifestations in Patients with GATA2 Deficiency
por: Amarnani, Abhimanyu A., et al.
Publicado: (2020)

Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
por: Ishiguro, Kazuya, et al.
Publicado: (2018)

Herpetic ocular manifestations in a patient with GATA2 deficiency
por: Ortueta-Olartecoechea, Ana I., et al.
Publicado: (2018)

Single Center Experience With Pediatric Patients With GATA2 Deficiency
por: Ovsyannikova, Galina, et al.
Publicado: (2022)

Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution
por: Fabiani, Emiliano, et al.
Publicado: (2023)

Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets
por: Mori, Minako, et al.
Publicado: (2023)

Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature
por: Gao, Juehua, et al.
Publicado: (2014)

Case Report of an Adolescent Male With Unexplained Pancytopenia: GATA2-Associated Bone Marrow Failure and Genetic Testing
por: Azevedo, Lauren, et al.
Publicado: (2017)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
por: Schwartz, Jason R., et al.
Publicado: (2021)

Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
por: Stoddart, Angela, et al.
Publicado: (2011)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
por: Fianchi, Luana, et al.
Publicado: (2012)

Intrasinusoidal proerythroblast infiltration in therapy related myeloid neoplasm
por: Li, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kpj1244sre2otchflr4018eha5